Aier Eye Hospital Group Co., Ltd. (300015.SZ)
CNY 12.98
(-0.15%)
CNY 12.98
(-0.15%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 5.39 Billion CNY | 16.74% |
| 2022 | 4.1 Billion CNY | 15.28% |
| 2021 | 3.56 Billion CNY | 35.18% |
| 2020 | 2.63 Billion CNY | 5.29% |
| 2019 | 2.5 Billion CNY | 26.21% |
| 2018 | 1.98 Billion CNY | 23.76% |
| 2017 | 1.6 Billion CNY | 39.89% |
| 2016 | 1.14 Billion CNY | 31.08% |
| 2015 | 874.33 Million CNY | 33.14% |
| 2014 | 656.7 Million CNY | 13.45% |
| 2013 | 578.83 Million CNY | 19.7% |
| 2012 | 483.56 Million CNY | -0.94% |
| 2011 | 488.13 Million CNY | 51.96% |
| 2010 | 321.23 Million CNY | 47.8% |
| 2009 | 217.34 Million CNY | 32.57% |
| 2008 | 163.94 Million CNY | 32.02% |
| 2007 | 124.18 Million CNY | 63.65% |
| 2006 | 75.88 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 1.18 Billion CNY | 17.71% |
| 2024 Q2 | 1.39 Billion CNY | 17.1% |
| 2024 Q3 | 1.41 Billion CNY | -1.16% |
| 2023 FY | 4.79 Billion CNY | 16.74% |
| 2023 Q3 | 1.25 Billion CNY | -5.23% |
| 2023 Q4 | 1 Billion CNY | -19.86% |
| 2023 Q2 | 1.32 Billion CNY | 10.73% |
| 2023 Q1 | 1.19 Billion CNY | 43.09% |
| 2022 Q3 | 1.26 Billion CNY | 26.65% |
| 2022 FY | 4.1 Billion CNY | 15.28% |
| 2022 Q1 | 1 Billion CNY | 33.36% |
| 2022 Q2 | 1 Billion CNY | -0.23% |
| 2022 Q4 | 838.54 Million CNY | -33.82% |
| 2021 Q3 | 1.1 Billion CNY | 31.09% |
| 2021 Q2 | 845.52 Million CNY | -1.5% |
| 2021 Q1 | 858.37 Million CNY | 3.48% |
| 2021 FY | 3.56 Billion CNY | 35.18% |
| 2021 Q4 | 751.95 Million CNY | -32.16% |
| 2020 Q2 | 526.2 Million CNY | 18.5% |
| 2020 Q3 | 836.98 Million CNY | 59.06% |
| 2020 Q4 | 829.54 Million CNY | -0.89% |
| 2020 FY | 2.63 Billion CNY | 5.29% |
| 2020 Q1 | 444.05 Million CNY | -28.0% |
| 2019 Q3 | 741.99 Million CNY | 34.58% |
| 2019 Q1 | 594.12 Million CNY | 30.41% |
| 2019 FY | 2.5 Billion CNY | 26.21% |
| 2019 Q4 | 616.77 Million CNY | -16.88% |
| 2019 Q2 | 551.35 Million CNY | -7.2% |
| 2018 Q1 | 433.41 Million CNY | -2.35% |
| 2018 Q3 | 527.79 Million CNY | -6.98% |
| 2018 Q4 | 455.59 Million CNY | -13.68% |
| 2018 FY | 1.98 Billion CNY | 23.76% |
| 2018 Q2 | 567.41 Million CNY | 30.92% |
| 2017 Q3 | 452.83 Million CNY | 17.38% |
| 2017 Q4 | 443.85 Million CNY | -1.98% |
| 2017 FY | 1.6 Billion CNY | 39.89% |
| 2017 Q1 | 320.74 Million CNY | 5.64% |
| 2017 Q2 | 385.79 Million CNY | 20.28% |
| 2016 FY | 1.14 Billion CNY | 31.08% |
| 2016 Q1 | 251.86 Million CNY | 25.83% |
| 2016 Q2 | 282.73 Million CNY | 12.25% |
| 2016 Q3 | 307.83 Million CNY | 8.88% |
| 2016 Q4 | 303.6 Million CNY | -1.37% |
| 2015 Q4 | 200.15 Million CNY | -29.25% |
| 2015 Q3 | 282.9 Million CNY | 25.17% |
| 2015 Q2 | 226.02 Million CNY | 36.78% |
| 2015 Q1 | 165.24 Million CNY | 7.05% |
| 2015 FY | 874.33 Million CNY | 33.14% |
| 2014 Q2 | 168.03 Million CNY | 21.1% |
| 2014 FY | 656.7 Million CNY | 13.45% |
| 2014 Q4 | 154.36 Million CNY | -21.06% |
| 2014 Q3 | 195.54 Million CNY | 16.38% |
| 2014 Q1 | 138.75 Million CNY | -6.41% |
| 2013 Q4 | 148.25 Million CNY | -11.44% |
| 2013 FY | 578.83 Million CNY | 19.7% |
| 2013 Q1 | 120.94 Million CNY | -5.72% |
| 2013 Q2 | 142.22 Million CNY | 17.59% |
| 2013 Q3 | 167.4 Million CNY | 17.7% |
| 2012 Q1 | 96.22 Million CNY | -32.32% |
| 2012 Q4 | 128.28 Million CNY | -10.87% |
| 2012 Q3 | 143.92 Million CNY | 25.01% |
| 2012 Q2 | 115.12 Million CNY | 19.64% |
| 2012 FY | 483.56 Million CNY | -0.94% |
| 2011 Q3 | 138.01 Million CNY | 21.23% |
| 2011 Q1 | 94.09 Million CNY | 5.37% |
| 2011 Q2 | 113.84 Million CNY | 20.99% |
| 2011 Q4 | 142.17 Million CNY | 3.01% |
| 2011 FY | 488.13 Million CNY | 51.96% |
| 2010 FY | 321.23 Million CNY | 47.8% |
| 2010 Q2 | 72.5 Million CNY | 12.96% |
| 2010 Q1 | 64.18 Million CNY | 9.7% |
| 2010 Q3 | 95.24 Million CNY | 31.37% |
| 2010 Q4 | 89.3 Million CNY | -6.24% |
| 2009 Q1 | 47.21 Million CNY | 4.14% |
| 2009 FY | 217.34 Million CNY | 32.57% |
| 2009 Q4 | 58.51 Million CNY | -7.65% |
| 2009 Q3 | 63.35 Million CNY | 31.29% |
| 2009 Q2 | 48.25 Million CNY | 2.21% |
| 2008 FY | 163.94 Million CNY | 32.02% |
| 2008 Q3 | 48.91 Million CNY | 0.0% |
| 2008 Q4 | 45.33 Million CNY | -7.31% |
| 2007 FY | 124.18 Million CNY | 63.65% |
| 2006 FY | 75.88 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| C.Q. Pharmaceutical Holding Co., Ltd. | 5.27 Billion CNY | -2.404% |
| Meinian Onehealth Healthcare Holdings Co., Ltd. | 3.77 Billion CNY | -42.878% |